Epilipsa 250mg Tablets

Indications

Epilipsa 250mg Tablets is primarily indicated in conditions like Anxiety, Epilepsy, Myoclonic seizures, and can also be given in adjunctive therapy as an alternative drug of choice in Alzheimer’s disease, Autism, Iron deficiency anaemia, Neuropathic pain, Tourette’s syndrome.

Contraindication

Epilipsa 250mg Tablets is contraindicated in conditions like Breast feeding.

Side Effects

The severe or irreversible adverse effects of Epilipsa 250mg Tablets , which give rise to further complications include Thrombocytopenia, Neutropenia, Pancytopenia.Epilipsa 250mg Tablets produces potentially life-threatening effects which include Hepatic impairment. which are responsible for the discontinuation of Epilipsa 250mg Tablets therapy. The symptomatic adverse reactions produced by Epilipsa 250mg Tablets are more or less tolerable and if they become severe, they can be treated symptomatically, these include Weakness, Dizziness, Vertigo, Headache, Drowsiness, Ataxia, Alopecia, Anorexia, Nervousness, Rashes, Depression, Somnolence, Tremor, Diplopia, Asthenia, Aggression, Alopecia, nervousness, Nervousness, dizziness, Ataxia, Weakness.

 Warnings

Epilipsa 250mg Tablets should be used with caution in patients with hepatic impairment (Halve dose in severe hepatic impairment due to cocomitant renal impairment); renal impairment (May need dose reduction a/c to creatinine clearance); pregnancy (use only if potential benefits outweighs risk); avoid sudden withdrawl.